CalciMedica CALC
NASDAQ CALC
$1.61 -0.07 (-4.17%)
As of: Sep 29, 2026 · 3:59 PM EDT

CalciMedica (CALC) EBITDA Margin (2024)

Updated

CalciMedica's EBITDA Margin came in at -2877.57% for Q4 2024, down 252.80 percentage points from the prior quarter.

Analysis

CalciMedica (CALC) EBITDA Margin (2024) Analysis & Trends

For FY2024, CalciMedica's EBITDA Margin was -2381.26%.

  • Business Quant data shows CALC's EBITDA Margin at -2624.77% (Q3 2024), -2368.73% (Q2 2024) and -1873.62% (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 CalciMedica 5.81 Mn -12.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,877.57%
Sep 30, 2024 -2,624.77%
Jun 30, 2024 -2,368.73%
Mar 31, 2024 -1,873.62%
API Access

CalciMedica EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CALC&period=max&api_key=YOUR_API_KEY